Stocks and InvestingStocks and Investing
Mon, July 10, 2023
Sun, July 9, 2023
Fri, July 7, 2023
Thu, July 6, 2023

Brian Tanquilut Downgraded (AMED) to Hold and Increased Target to $101 on, Jul 6th, 2023


Published on 2024-10-28 04:40:22 - WOPRAI, Brian Tanquilut
  Print publication without navigation


Brian Tanquilut of Jefferies, Downgraded "Amedisys, Inc." (AMED) to Hold and Increased Target from $98 to $101 on, Jul 6th, 2023.

Brian has made no other calls on AMED in the last 4 months.



There are 7 other peers that have a rating on AMED. Out of the 7 peers that are also analyzing AMED, all agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Bill Sutherland of "Benchmark" Downgraded from Strong Buy to Hold on, Wednesday, June 28th, 2023
  • David Macdonald of "Truist Securities" Maintained at Hold with Increased Target to $101 on, Tuesday, June 27th, 2023
  • Jonathan Yong of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $100 on, Tuesday, June 6th, 2023
  • Sarah James of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $100 on, Tuesday, June 6th, 2023
  • Gary Taylor of "TD Cowen" Maintained at Hold with Decreased Target to $84 on, Monday, May 8th, 2023
  • Steve Valiquette of "Barclays" Maintained at Hold with Decreased Target to $88 on, Friday, May 5th, 2023
  • Scott Fidel of "Stephens & Co." Reiterated at Hold and Held Target at $103 on, Thursday, May 4th, 2023